1. Wang, Hongyun, Ye, Junrui, Peng, Ye, Zhang, Zhao, Chen, Naihong. 2023. CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction. In Autophagy, 20, 590-613. doi:10.1080/15548627.2023.2276639. https://pubmed.ncbi.nlm.nih.gov/37908119/
2. Qin, Xiaodan, Lam, Andrew, Zhang, Xu, George, Rani E, Feng, Hui. 2024. CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness. In Science advances, 10, eadh9547. doi:10.1126/sciadv.adh9547. https://pubmed.ncbi.nlm.nih.gov/38489372/
3. Li, Dan, Huang, Shenglan, Luo, Chen, Liu, Kan, Wu, Jianbing. 2023. CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma. In Current oncology (Toronto, Ont.), 30, 2653-2672. doi:10.3390/curroncol30030202. https://pubmed.ncbi.nlm.nih.gov/36975415/
4. Dunne, Philip D, O'Reilly, Paul G, Coleman, Helen G, Lawler, Mark, McArt, Darragh G. . Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer. In Oncotarget, 7, 36632-36644. doi:10.18632/oncotarget.9126. https://pubmed.ncbi.nlm.nih.gov/27153559/